301 related articles for article (PubMed ID: 19351844)
1. Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.
Braggio E; Keats JJ; Leleu X; Van Wier S; Jimenez-Zepeda VH; Valdez R; Schop RF; Price-Troska T; Henderson K; Sacco A; Azab F; Greipp P; Gertz M; Hayman S; Rajkumar SV; Carpten J; Chesi M; Barrett M; Stewart AK; Dogan A; Bergsagel PL; Ghobrial IM; Fonseca R
Cancer Res; 2009 Apr; 69(8):3579-88. PubMed ID: 19351844
[TBL] [Abstract][Full Text] [Related]
2. High-resolution genomic analysis in Waldenström's macroglobulinemia identifies disease-specific and common abnormalities with marginal zone lymphomas.
Braggio E; Keats JJ; Leleu X; Wier SV; Jimenez-Zepeda VH; Schop RF; Chesi M; Barrett M; Stewart AK; Dogan A; Bergsagel PL; Ghobrial IM; Fonseca R
Clin Lymphoma Myeloma; 2009 Mar; 9(1):39-42. PubMed ID: 19362969
[TBL] [Abstract][Full Text] [Related]
3. High-throughput genomic analysis in Waldenström's macroglobulinemia.
Poulain S; Braggio E; Roumier C; Aijjou R; Broucqsault N; Galiègue-Zouitina S; Manier S; Soenen V; Nibourel O; Duthilleul P; Fonseca R; Leleu X
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):106-8. PubMed ID: 21454205
[TBL] [Abstract][Full Text] [Related]
4. Isochromosome (6p) in Waldenstrom's macroglobulinemia.
White AD; Clark RE; Jacobs A
Cancer Genet Cytogenet; 1992 Jan; 58(1):89-91. PubMed ID: 1728957
[TBL] [Abstract][Full Text] [Related]
5. Genomic abnormalities of Waldenström macroglobulinemia and related low-grade B-cell lymphomas.
Braggio E; Fonseca R
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):198-201. PubMed ID: 23477936
[TBL] [Abstract][Full Text] [Related]
6. MYD88 L265P somatic mutation in Waldenström's macroglobulinemia.
Treon SP; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Sheehy P; Manning RJ; Patterson CJ; Tripsas C; Arcaini L; Pinkus GS; Rodig SJ; Sohani AR; Harris NL; Laramie JM; Skifter DA; Lincoln SE; Hunter ZR
N Engl J Med; 2012 Aug; 367(9):826-33. PubMed ID: 22931316
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.
Nguyen-Khac F; Lambert J; Chapiro E; Grelier A; Mould S; Barin C; Daudignon A; Gachard N; Struski S; Henry C; Penther D; Mossafa H; Andrieux J; Eclache V; Bilhou-Nabera C; Luquet I; Terre C; Baranger L; Mugneret F; Chiesa J; Mozziconacci MJ; Callet-Bauchu E; Veronese L; Blons H; Owen R; Lejeune J; Chevret S; Merle-Beral H; Leblondon V; ; ;
Haematologica; 2013 Apr; 98(4):649-54. PubMed ID: 23065509
[TBL] [Abstract][Full Text] [Related]
8. MYD88 L265P mutation in Waldenstrom macroglobulinemia.
Poulain S; Roumier C; Decambron A; Renneville A; Herbaux C; Bertrand E; Tricot S; Daudignon A; Galiègue-Zouitina S; Soenen V; Theisen O; Grardel N; Nibourel O; Roche-Lestienne C; Quesnel B; Duthilleul P; Preudhomme C; Leleu X
Blood; 2013 May; 121(22):4504-11. PubMed ID: 23532735
[TBL] [Abstract][Full Text] [Related]
9. Aggressive Lymphoplasmacytic Neoplasm With an Unusual In-frame Deletion of
Yan M; Meyerson H; Oduro KA; Shetty S; Yoest J
Int J Surg Pathol; 2024 Feb; 32(1):5-10. PubMed ID: 37093763
[TBL] [Abstract][Full Text] [Related]
10. Genome wide SNP array identified multiple mechanisms of genetic changes in Waldenstrom macroglobulinemia.
Poulain S; Roumier C; Galiègue-Zouitina S; Daudignon A; Herbaux C; Aiijou R; Lainelle A; Broucqsault N; Bertrand E; Manier S; Renneville A; Soenen V; Tricot S; Roche-Lestienne C; Duthilleul P; Preudhomme C; Quesnel B; Morel P; Leleu X
Am J Hematol; 2013 Nov; 88(11):948-54. PubMed ID: 23861223
[TBL] [Abstract][Full Text] [Related]
11. Genomic studies have identified multiple mechanisms of genetic changes in Waldenström macroglobulinemia.
Poulain S; Herbaux C; Bertrand E; Decambron A; Fouquet G; Boyle E; Gay J; Manier S; Duthilleul P; Roumier C; Leleu X
Clin Lymphoma Myeloma Leuk; 2013 Apr; 13(2):202-4. PubMed ID: 23473949
[TBL] [Abstract][Full Text] [Related]
12. Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191.
Ni H; Shirazi F; Baladandayuthapani V; Lin H; Kuiatse I; Wang H; Jones RJ; Berkova Z; Hitoshi Y; Ansell SM; Treon SP; Thomas SK; Lee HC; Wang Z; Davis RE; Orlowski RZ
Clin Cancer Res; 2018 Dec; 24(24):6408-6420. PubMed ID: 30126942
[TBL] [Abstract][Full Text] [Related]
13. Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma.
Otto C; Giefing M; Massow A; Vater I; Gesk S; Schlesner M; Richter J; Klapper W; Hansmann ML; Siebert R; Küppers R
Br J Haematol; 2012 Jun; 157(6):702-8. PubMed ID: 22469134
[TBL] [Abstract][Full Text] [Related]
14. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.
Yang G; Zhou Y; Liu X; Xu L; Cao Y; Manning RJ; Patterson CJ; Buhrlage SJ; Gray N; Tai YT; Anderson KC; Hunter ZR; Treon SP
Blood; 2013 Aug; 122(7):1222-32. PubMed ID: 23836557
[TBL] [Abstract][Full Text] [Related]
15. The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis.
Hunter ZR; Xu L; Yang G; Zhou Y; Liu X; Cao Y; Manning RJ; Tripsas C; Patterson CJ; Sheehy P; Treon SP
Blood; 2014 Mar; 123(11):1637-46. PubMed ID: 24366360
[TBL] [Abstract][Full Text] [Related]
16. [Molecular basis of Waldenström macroglobulinemia].
Sevčíková S; Novák L; Kubiczková L; Dementyeva E; Ríhová L; Hájek R
Klin Onkol; 2012; 25(6):413-20. PubMed ID: 23301642
[TBL] [Abstract][Full Text] [Related]
17.
Poulain S; Roumier C; Bertrand E; Renneville A; Caillault-Venet A; Doye E; Geffroy S; Sebda S; Nibourel O; Nudel M; Herbaux C; Renaud L; Tomowiak C; Guidez S; Tricot S; Roche-Lestienne C; Quesnel B; Preudhomme C; Leleu X
Clin Cancer Res; 2017 Oct; 23(20):6325-6335. PubMed ID: 28754818
[No Abstract] [Full Text] [Related]
18. Chromosomal abnormalities in Waldenström's macroglobulinemia.
Carbone P; Caradonna F; Granata G; Marcenò R; Cavallaro AM; Barbata G
Cancer Genet Cytogenet; 1992 Jul; 61(2):147-51. PubMed ID: 1638495
[TBL] [Abstract][Full Text] [Related]
19. Genetic factors and pathogenesis of Waldenström's macroglobulinemia.
Monge J; Braggio E; Ansell SM
Curr Oncol Rep; 2013 Oct; 15(5):450-6. PubMed ID: 23901022
[TBL] [Abstract][Full Text] [Related]
20. [Gene mutations connected to Waldenstöm macroglobulinemia].
Kutálková K; Sedlaříková L; Adam Z; Ševčíková S
Vnitr Lek; 2016 Jan; 62(1):40-3. PubMed ID: 26967235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
